Pharma startup Pharmaoffer is fighting global medicine shortage through pharmaceutical supply chain transformation

The global pharmaceutical market is over $1 trillion mark and is projected to grow at 6.3% CAGR through 2022. With all the technology advancements in drug research and medicine, the pharmaceutical supply chain is still lagging behind in digital transformation compared to other industries. Getting the required ingredients and raw materials from suppliers to the buyer is rife with complexity and cumbersome processes. It is a market that is ripe for disruption. Enter Pharmaoffer, a Dutch pharma startup and an online marketplace for pharmaceutical raw materials that is streamlining the entire pharma supply chain process and connecting buyers with suppliers of pharmaceutical ingredients (APIs, Excipients and Intermediates).

Today, the company announced its collaborating with pharmaceutical suppliers to resolve medicine shortages around the world. Through its global B2B platform, suppliers of pharmaceutical raw materials can offer their products directly to the buyers. Pharmaoffer enables producers of medicines to easily find new qualified suppliers for their raw material needs. Pharmaoffer simplifies and transforms the supply chain process by cutting out the middleman and provides a transparent solution that reduces expenses and unnecessary delays in the supply chain by giving more control to all parties involve. Through its platform, Pharmaoffer has successfully connected buyers and supplier from 172 countries.

Founded in 2016, Pharmaoffer is a global B2B online platform for buyers and suppliers of pharmaceutical ingredients (APIs, Excipients and Intermediates). Suppliers listed on its platform can manage their company page by adding products and showing their quality certificates. Buyers can use Pharmaoffer to find an overview of all worldwide manufacturers and send inquiries and orders directly to the supplier of their choice. Pharmaoffer has created an easy to use online platform free from advertisement.

“The pharmaceutical industry is lagging 15 years behind with digital innovation compared to other markets. Worldwide, pharmacists are struggling to find high-quality pharmaceutical raw materials necessary for the production of safe medicine. To solve this problem the industry needs to digitize. In our day-to-day life we are used to the benefits of transparent platforms such as Airbnb, Booking.com or Amazon. One place with all available parties. These platforms give us more choice of suppliers, faster services, better prices and safer transactions. The future of pharma is digital and we believe that pharmaceutical buyers and suppliers should enjoy the same benefits too. That’s why we started Pharmaoffer.”

For the production of medicines, companies need raw materials from qualified suppliers. Medicines are a combination of active pharmaceutical ingredients (the actual drug itself) and excipients (inactive ingredients which are used as fillers/binders/coatings of the tablet). The process of finding new qualified suppliers for these raw materials is time-consuming because of all laws and regulations. With Pharmaoffer, buyers are no longer limited to their network of suppliers.